Oak Longevity vs bmiMD: Pricing, meds, and subscription compared
Quick verdict: Oak Longevity vs bmiMD
Oak Longevity is best for cost-conscious patients seeking semaglutide from $133/month and tirzepatide from $199/month without a subscription, while bmiMD centers on compounded tirzepatide with multi-month plans that lower the monthly equivalent to $139/month on a 12-month plan. This comparison focuses on pricing and billing structure, medication selection, clinician access and review, refunds and guarantees, and regulatory notes.
See Oak Longevity pricing and start the online review
Direct comparison: five key differences
1. Price and billing structure
Oak Longevity lists semaglutide from $133/month and tirzepatide from $199/month with one flat price that covers all dosages and no subscription. Billing is monthly on a non-recurring basis; three-month prescriptions are billed upfront and Oak states no refunds are available after physician approval and once medication has shipped.
bmiMD offers compounded tirzepatide with four billing options: month-to-month $179, 3-month $159/month, 6-month $149/month, and 12-month $139/month. bmiMD markets a lower long-term monthly equivalent but the lowest price requires a longer commitment and the total prepaid charge should be confirmed.
View bmiMD tirzepatide billing options
2. Medication selection and dosing price model
Oak sells compounded semaglutide and compounded tirzepatide, noting one flat price covers all dosages. bmiMD focuses on compounded tirzepatide and states the same price at every dose, with pricing tiers based on plan length.
3. Subscription, clinician access, and review process
Oak emphasizes no subscriptions, no membership fees, free health coaching, free shipping, and an asynchronous clinician review that does not require a video call. Oak says board-certified physicians in your state review every case and same-day approval is available for qualifying patients.
bmiMD offers free subscription shipping, online refills and delivery, and 24/7 clinician access. Treatment is clinician-reviewed and bmiMD highlights easy refills delivered to your door and confirmation of potency every 3 to 6 months to stay within target strength.
Compare Oak’s no-subscription approach
4. Refunds, guarantees, and prepaid terms
Oak states no refunds are available after physician approval and once medication has shipped; three-month prescriptions are billed upfront. bmiMD advertises “100% Risk Free” and says it is “100% Refundable if not eligible for program,” while also noting the lowest monthly rate requires a 12-month commitment and that total prepaid charge should be confirmed.
5. Regulatory and eligibility notes
Both providers offer compounded medications. Oak explicitly notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Oak also states patients with BMI below 20 do not qualify for GLP-1 treatment and lists contraindications such as not for patients under 18, pregnant, or nursing. bmiMD likewise notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Comparison table: Oak Longevity vs bmiMD
| Criteria | Oak Longevity | bmiMD |
|---|---|---|
| Starting price | Semaglutide from $133/month; tirzepatide from $199/month | Tirzepatide month-to-month $179; 3, 6, 12 month plans down to $139/month |
| Medication options | Compounded semaglutide and compounded tirzepatide | Compounded tirzepatide (GLP-1/GIP) |
| Subscription requirement | No subscriptions or membership fees; billed non-recurring | Subscription-style plans with free shipping; lower monthly with longer plans |
| Clinician access and review | Asynchronous clinician review, no video call required; board-certified physicians review each case | 24/7 clinician access and online refills; confirmed potency checks every 3–6 months |
| Refunds and guarantees | No refunds after physician approval and once medication has shipped | 100% refundable if not eligible for program; confirm total prepaid charge |
| Shipping | Free shipping with tracking | Free shipping on every subscription order |
| Regulatory note | Compounded medications not FDA-approved | Compounded medications not FDA-approved |
How to decide: clinical and financial trade offs
If your priority is the lowest advertised month-to-month price on semaglutide or avoiding any subscription commitment, Oak Longevity provides semaglutide from $133/month, tirzepatide from $199/month, no subscriptions, and an asynchronous clinician review. If you prefer tirzepatide and are willing to commit to multiple months to reach a lower long-term monthly equivalent, bmiMD lists lower rates for 3, 6, and 12 month plans with free subscription shipping and 24/7 clinician access.
See bmiMD plan lengths and clinician access
Start Oak Longevity eligibility and pricing check
Conclusion: Oak Longevity vs bmiMD
Oak Longevity vs bmiMD comes down to billing style and medication focus. Oak is better for cost-conscious patients who want semaglutide availability, one flat price for all dosages, no subscription, free coaching and free shipping. bmiMD is better for people seeking compounded tirzepatide with multi-month plans that lower the monthly equivalent to $139/month on a 12-month plan and who want ongoing clinician access and a refund if ineligible.
Choose Oak Longevity if you want semaglutide from $133/month, tirzepatide from $199/month, no subscription, asynchronous clinician review, and free health coaching. Choose bmiMD if you want compounded tirzepatide with multi-month plans and 24/7 clinician access and are comfortable confirming prepaid terms.